Iradimed Corp (NASDAQ:IRMD) VP Brent Johnson Sells 1,000 Shares

Iradimed Corp (NASDAQ:IRMD) VP Brent Johnson sold 1,000 shares of Iradimed stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $20.00, for a total transaction of $20,000.00. Following the sale, the vice president now owns 2,368 shares of the company’s stock, valued at approximately $47,360. The sale was disclosed in a document filed with the SEC, which is available through this link.

Brent Johnson also recently made the following trade(s):

  • On Thursday, September 12th, Brent Johnson sold 1,000 shares of Iradimed stock. The shares were sold at an average price of $20.25, for a total transaction of $20,250.00.
  • On Wednesday, August 21st, Brent Johnson sold 1,000 shares of Iradimed stock. The shares were sold at an average price of $20.62, for a total transaction of $20,620.00.
  • On Monday, August 19th, Brent Johnson sold 1,000 shares of Iradimed stock. The shares were sold at an average price of $21.21, for a total transaction of $21,210.00.
  • On Friday, August 16th, Brent Johnson sold 2,000 shares of Iradimed stock. The shares were sold at an average price of $20.92, for a total transaction of $41,840.00.
  • On Wednesday, August 14th, Brent Johnson sold 1,000 shares of Iradimed stock. The shares were sold at an average price of $21.10, for a total transaction of $21,100.00.
  • On Monday, August 12th, Brent Johnson sold 1,000 shares of Iradimed stock. The shares were sold at an average price of $21.27, for a total transaction of $21,270.00.
  • On Friday, August 9th, Brent Johnson sold 2,400 shares of Iradimed stock. The shares were sold at an average price of $21.81, for a total transaction of $52,344.00.
  • On Monday, August 5th, Brent Johnson sold 3,000 shares of Iradimed stock. The shares were sold at an average price of $21.94, for a total transaction of $65,820.00.
  • On Wednesday, August 7th, Brent Johnson sold 7,000 shares of Iradimed stock. The shares were sold at an average price of $21.93, for a total transaction of $153,510.00.
  • On Friday, August 2nd, Brent Johnson sold 5,000 shares of Iradimed stock. The shares were sold at an average price of $22.83, for a total transaction of $114,150.00.

NASDAQ IRMD opened at $20.31 on Friday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 9.39 and a current ratio of 10.29. The company has a market capitalization of $230.93 million, a price-to-earnings ratio of 47.23 and a beta of 1.67. The company’s 50-day simple moving average is $20.32 and its two-hundred day simple moving average is $22.67. Iradimed Corp has a one year low of $16.68 and a one year high of $38.78.

Institutional investors have recently modified their holdings of the company. HM Payson & Co. purchased a new position in shares of Iradimed in the 2nd quarter worth approximately $89,000. Victory Capital Management Inc. purchased a new position in shares of Iradimed in the 1st quarter worth approximately $212,000. Charles Schwab Investment Management Inc. grew its position in shares of Iradimed by 34.0% in the 2nd quarter. Charles Schwab Investment Management Inc. now owns 10,500 shares of the medical equipment provider’s stock worth $215,000 after buying an additional 2,666 shares during the last quarter. Marshall Wace LLP purchased a new position in shares of Iradimed in the 1st quarter worth approximately $241,000. Finally, Morgan Stanley grew its position in shares of Iradimed by 14.3% in the 2nd quarter. Morgan Stanley now owns 13,118 shares of the medical equipment provider’s stock worth $268,000 after buying an additional 1,637 shares during the last quarter. 30.63% of the stock is currently owned by hedge funds and other institutional investors.

A number of research firms have commented on IRMD. Zacks Investment Research downgraded shares of Iradimed from a “buy” rating to a “hold” rating in a research report on Wednesday, July 3rd. ValuEngine raised shares of Iradimed from a “sell” rating to a “hold” rating in a research report on Wednesday, July 31st.

About Iradimed

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system.

Further Reading: What are the Benefits of Index Funds?

Insider Buying and Selling by Quarter for Iradimed (NASDAQ:IRMD)

Receive News & Ratings for Iradimed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iradimed and related companies with MarketBeat.com's FREE daily email newsletter.